← Eichor
Study identifier: NCT07050212 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation

Condition: Remimazolam · Dexmedetomidine · Esketamine  ·  Sponsor: Maternal and Child Health Hospital of Hubei Province

PhaseNA
Planned participants150
Who can joinAll sexes, 2 Years to 5 Years
Healthy volunteersYes

About this study

By comparing the application effects of three drugs in pediatric preoperative sedation, this study explores the optimal medication regimen, aiming to provide safer, more effective, and more personalized medication options for pediatric preoperative sedation. Additionally, this research will also focus on the impact of these three drugs on postoperative agitation in children, offering valuable references for the overall management of pediatric surgical anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

NaLi, MD  ·  +862763490107  ·  lina@hbfy.com

Always discuss trial participation with your own doctor first.

Locations (1)

Maternal and Child Health Hospital of Hubei ProvinceWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07050212